However, the IGF-I gene expression decreased with increasing severity of MASLD, suggesting that reductions of hepatic IGF-I production in patients with MASLD may be related to the severity of the damaged hepatocytes. Here, IGF1 is linked to metabolic dysfunction-associated steatotic liver disease.